Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis

NCT07424950 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: bomedemstat

Sponsor

United Lincolnshire Hospitals NHS Trust

Collaborators

University of Lincoln